News

6 things the hospital-at-home model needs to scale up nationally

Earlier this year Congress extended CMS’s hospital-at-home waiver for five years via the Consolidated Appropriations Act of 2026. With that bold stroke, ‘HaH’ services became eligible for Medicare reimbursement through September of 2030.

IV fluids recalled over possible contamination—patients face risk of vascular complications

Particulate matter may be present in certain 1-liter containers of B. Braun Medical's Lactated Ringer's Injections. If this enters a patient's circulatory system, it could lead to a series of adverse events.

Fearless futurist: ‘In Phase One, AI felt like software. In Phase Two, it feels like a new species of workforce.’

The nonfiction book market is flooded with titles mentioning AI or artificial intelligence. Here’s a new work that will shake your world whether you’re an AI lover, loather or someone in between.

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

cvi42 | Plaque Circle Cardiovascular Imaging

How to implement AI-powered coronary plaque analysis software—and ensure you get paid

The use of AI to evaluate plaque buildup in CCTA images has been one of cardiology’s biggest ongoing trends. Implementing this software into existing workflows, however, can be a challenge. An upcoming webinar is focused on providing guidance to hospitals and cardiology practices hoping to learn more about this topic.

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

congress money medicare washington DC senate house

Radiation oncologists converge on Capitol Hill to push for payment reform

American Society for Radiation Oncology members from across the country took part in ASTRO’s annual advocacy day on April 27.

Radiology department says simple, low-cost strategy can bolster workplace cohesion

Chicago imaging leaders have sought to address isolation and its ill effects through the implementation of daily “happy birthday” emails to department employees.

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

Multiple GLP-1 drugs linked to lower AFib risk

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.

Lawmakers introduce bipartisan bill to speed up prior authorization in Medicare Advantage

Several healthcare stakeholders have voiced their support for the effort, including the Medical Group Management Association.

Radiologists among docs most optimistic about profession’s short-term future

However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.

survey polling quick data check mark poll research doctor

Current political climate having 'detrimental' effect on radiology research, survey says

Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.

Around the web

Health Exec

6 things the hospital-at-home model needs to scale up nationally

Cardiovascular Business

IV fluids recalled over possible contamination—patients face risk of vascular complications

Health Exec

Fearless futurist: ‘In Phase One, AI felt like software. In Phase Two, it feels like a new species of workforce.’

The nonfiction book market is flooded with titles mentioning AI or artificial intelligence. Here’s a new work that will shake your world whether you’re an AI lover, loather or someone in between.